Compare VSAT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSAT | TECH |
|---|---|---|
| Founded | 1986 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 11.4B |
| IPO Year | 1996 | 1995 |
| Metric | VSAT | TECH |
|---|---|---|
| Price | $71.14 | $72.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 13 |
| Target Price | ★ $103.94 | $70.50 |
| AVG Volume (30 Days) | 1.4M | ★ 2.9M |
| Earning Date | 11-06-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | 94.42 | ★ 152.17 |
| EPS | N/A | ★ 1.16 |
| Revenue | N/A | ★ $1,215,039,000.00 |
| Revenue This Year | $4.53 | $4.35 |
| Revenue Next Year | $4.59 | $10.04 |
| P/E Ratio | ★ N/A | $62.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.13 | $43.20 |
| 52 Week High | $93.03 | $72.69 |
| Indicator | VSAT | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 57.53 |
| Support Level | $67.16 | $72.11 |
| Resistance Level | $77.90 | $72.66 |
| Average True Range (ATR) | 3.47 | 0.15 |
| MACD | -0.23 | -0.05 |
| Stochastic Oscillator | 31.87 | 55.05 |
Viasat Inc an world-wide provider of communications technologies and services, focused on making connectivity accessible, available and secure for current and future customers world-wide. The company has two reportable segments: communication services and defense and advanced technologies. It generates majority of revenue from communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers. It has presence in United States and Outside United States. The company generates majority of revenue from United States. Its products are Antennas, Terminals & radios, Modems, Semiconductors, Cybersecurity, Software & services, Home internet.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.